Daily coverage of equity markets, sectors, and major indices.
In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.
29,904 total articles
Abundia Global Impact Group Inc. said it has agreed to a registered direct offering to raise approximately $20 million in gross proceeds, triggering a 14.6% drop in its stock. The proceeds are earmarked for completing a Front-End Engineering and Design (FEED) study, finalizing the acquisition of RPD Technologies, reducing debt, beginning constructi…
Blue Hat Interactive Entertainment Technology (NASDAQ:BHAT) announced an underwritten public offering of 32 million units priced at $0.20 per unit, expected to raise roughly $6.4 million before fees. Each unit combines one ordinary share and one warrant, with the warrants exercisable immediately at an initial $0.20 exercise price and set to expire …
Piper Sandler's recent industry review finds internet stocks exhibiting resilience as digital advertising momentum builds into early 2026. January ad-market results came in modestly above prior expectations while February estimates rose further, underpinning positive trends across major platforms. Meta, Reddit and Roku stand out in the firm's ranki…
Celsius Holdings stock climbed 6.5% on Friday morning following the company's presentation at the Consumer Analyst Group of New York conference, where management outlined expected shelf-space gains from retailers' spring resets and discussed commercial initiatives, brand strength and international opportunity.
Summary: Rubico Inc disclosed a substantial issuance of common stock executed under an existing equity line of credit with B. Riley Principal Capital II, LLC, which raised outstanding shares from 567,651 to 4,059,924. The transaction, which involved 3,492,273 common shares with a par value of $0.01 each, produced a 19.6% drop in the company's share…
Twin Vee Powercats Co priced a best-efforts public offering at $0.47 per share for 6,383,000 common shares, prompting a 48.5% decline in premarket trading. Gross proceeds from the deal are expected to be about $3 million before fees, with the offering scheduled to close on February 23, 2026 subject to customary conditions. ThinkEquity is acting as …
Barclays urges investors to view recent geopolitical tensions as potential entry points, saying underlying economic and earnings fundamentals continue to support markets. The bank highlights a calming of AI-driven volatility, moderating single-stock swings and a tactical shift into old-economy and hard-asset sectors, while flagging upcoming corpora…
Candel Therapeutics Inc. (NASDAQ: CADL) saw its stock fall 9.9% in premarket trading after announcing the pricing of a public offering of 18,348,624 shares at $5.45 apiece, expected to generate gross proceeds of $100 million before underwriting discounts and commissions. The company said proceeds will support commercial preparation for aglatimagene…
UBS cut its rating on BorgWarner to Sell from Neutral while increasing its price target to $55 from $49, saying investor expectations for the company's TurboCell data center power product appear elevated. The bank acknowledged BorgWarner's search for new growth amid declines in legacy lines but flagged execution, commercialization and disclosure ga…
Nova Minerals Ltd. (NASDAQ:NVA) slid about 2% on Friday following a public disclosure from Spruce Point Capital Management that it had established a short position in the company. Spruce Point's report highlighted concerns over Nova's valuation, infrastructure and community obstacles at its Alaskan operations, gaps in proof of concept, a history of…
Mangoceuticals Inc. (NASDAQ:MGRX) shares climbed 70% in premarket trading after the telemedicine firm reported a 336% month-over-month increase in sales of its $99 per month injectable testosterone replacement therapy (TRT) program and a 54% reduction in customer acquisition costs. The program, launched in mid-December, bundles medical consultation…
Pleasant Lake Partners disclosed a stake of roughly 10% in Funko and urged the collectible toymaker to immediately and thoroughly evaluate strategic and financial alternatives, including a potential sale. The filing notes Fund 1 holds about 5.5 million shares and that Pleasant Lake is prepared to participate in a sale process, citing prior take-pri…
Kosmos Energy shares climbed about 9% in premarket trading following Ghana's parliamentary approval to extend petroleum licenses for the West Cape Three Points and Deepwater Tano agreements through 2040. The move covers the Jubilee and TEN fields and is expected to unlock up to $2 billion of additional investment, expand Jubilee drilling, and incre…
Envirotech Vehicles Inc. (NASDAQ: EVTV) saw premarket gains after Azio AI Corp. disclosed receipt of a purchase order for 28 next-generation ASIC compute systems from EVTV, with payment for the initial tranche completed. Azio AI plans to begin shipments in the coming weeks for installation inside EVTV's leased liquid-immersion-cooled modular contai…
President Donald Trump posted on his social media platform shortly before the Bureau of Economic Analysis released fourth-quarter GDP figures, suggesting the data would show weakness. The BEA reported a 1.4% annualized increase in inflation-adjusted GDP for Q4, below the 2.8% consensus and down from 4.4% in the prior quarter. The government estimat…
Bank of America's latest valuation review finds the S&P 500 broadly overvalued, with the index 'statistically expensive on 18 of 20 valuation metrics' and four measures near record highs. Analyst Savita Subramanian says the firm still expects earnings-driven multiple compression and maintains a year-end 2026 target of 7,100 for the benchmark, notin…
Tata Starbucks Pvt. is accelerating its store rollout in India and testing menu innovations such as protein foam coffee even as the unit reports widening losses. Company leadership says investment and growth are the priority over near-term profit, noting the business has returned to cash-positive operations but offering no timeline for reaching ful…
Morgan Stanley began coverage of GE Aerospace with an Overweight rating and a $425 price target, arguing the market is underestimating the company’s long-term free cash flow and pricing power. The jet engine maker’s shares rose 1.5% in Friday premarket trading. The bank’s projections show free cash flow rising materially through 2030 and a valuatio…
Blue Owl Capital's stock fell further in pre-market trading on Friday after the firm disclosed a package of asset sales and changes to a long-running debt vehicle. The move, which included selling $1.4 billion of assets across three funds and permanently halting redemptions at one vehicle, rattled investors and contributed to pressure across altern…
Citi's February 2026 House Views note says liquidity remains supportive of risk assets, but rising concerns about artificial intelligence have prompted the bank to adopt hedges. The firm stays overweight equities overall, reallocates half of its U.S. exposure into small caps, trims China and adjusts sector weights away from megacap growth toward in…
Iran and the United States are engaged in talks centered on ensuring that Iran's nuclear activities, including uranium enrichment, are and remain peaceful, Iranian Foreign Minister Abbas Araghchi said. Tehran has not offered to suspend its nuclear program, and Washington has not sought a full stop to enrichment, Araghchi added. Both sides are repor…
J.P. Morgan continues to rate Heidelberg Materials and Holcim as top European cement names, contending that each firm's scale, investments in carbon reduction and demonstrated pricing discipline should preserve profitability even under a more pessimistic EU carbon-price scenario. The bank’s work indicates modest cumulative price increases across th…
Two leading sell-side firms lowered their ratings or price targets on Reliance Inc., citing deteriorating gross margins, aluminum volatility and a valuation that may not leave room for upside. J.P. Morgan set a December 2026 target of $330 while BMO trimmed its target to $320. Both analysts acknowledged Reliance's market-share gains, counter-cyclic…
Organon & Co. shares climbed 6% on Friday morning after the company's audit committee, with outside counsel support, completed an independent review and concluded there was no improper conduct related to prior biosimilar purchases from a supplier. The committee reported the review did not identify any issues requiring adjustments to previously issu…
Barclays has begun coverage of U.S. large-cap biopharmaceuticals with a Neutral stance, identifying Eli Lilly, Merck, Bristol-Myers Squibb and AbbVie as its top picks. The bank cites improved policy clarity after most-favored-nation agreements, demographic and healthcare spending trends, and AI-driven productivity gains as reasons the sector could …
